Backstrom Jay T. 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Jul 10, 2025
Insider Transaction Report
Form 4
Backstrom Jay T.
Director
Transactions
- Award
Restricted stock units
2025-07-08+4,341→ 4,341 total→ Common stock (4,341 underlying) - Award
Stock options (right to buy)
2025-07-08+23,393→ 23,393 totalExercise: $36.28Exp: 2035-07-08→ Common stock (23,393 underlying)
Footnotes (3)
- [F1]This option was granted on July 8, 2025. The shares underlying this option vest as to 25% of the underlying shares on July 8, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The restricted stock units were granted on July 8, 2025. Beginning on July 8, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.